Jan 17, 2025 · The expectations of the Indian pharma industry from the Union Budget 2025 revolve around incentivising research, streamlining taxation frameworks, and fostering regulatory ease to bolster the sector’s growth and resilience in an evolving global landscape, says an expert from the business ...

Jan 8, 2025 · Biocon Biologics in its first anniversary as a fully integrated, global biosimilars company dedicated to expanding access to high-quality affordable biologic medicines for patients worldwide. This marks its emergence as a global enterprise operating in over 120 countries, supported by a diverse ...

Jan 20, 2025 · Daiichi Sankyo & AstraZeneca’s Datroway gets US FDA approval for patients with previously treated metastatic HR positive, HER2 negative breast cancer

Oct 25, 2024 · Pharmexcil calls on members to enroll as voters for 2024-26 elections: Shardul Nautiyal, Mumbai Friday, October 25, 2024, 08:00 Hrs [IST] The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is gearing up for its 2024-26 Committee of Administration (CoA) and vice chairman elections.

Jan 17, 2025 · Lilly's Omvoh receives US FDA approval to treat Crohn's disease in adults: Indianapolis Friday, January 17, 2025, 12:00 Hrs [IST] Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults.

Jan 2, 2025 · 2024 a landmark year for Indian pharma with advancements in manufacturing, tech & healthcare access: Shardul Nautiyal, Mumbai Thursday, January 2, 2025, 08:00 Hrs [IST]

Jan 17, 2025 · InflaRx N.V., a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced that the European Commission (EC) has granted marketing authorization under exceptional circumstances for Gohibic (vilobelimab) for the treatment of adult patients with SARS ...

Jan 10, 2025 · Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST]

2 days ago · CenExel, a leading network of clinical research sites, congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the US FDA approval of Journavx (suzetrigine), the first-in-class, non-opioid oral pain signal inhibitor for adults with moderate-to-severe ...

Jan 20, 2025 · Indian healthcare sector has been advocating for ‘industry status’ and benefits akin to those enjoyed by the Information Technology sector, particularly through Special Economic Zones (SEZs). With the Union Budget approaching, the healthcare sector is voicing its concerns and presenting key ...